San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...

Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...

Please provide your email address to receive an email when new articles are posted on . Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates ...

LOS ANGELES, CA — A transcatheter technique using primarily echocardiographically guided patent ductus arteriosus (PDA) closure in extremely premature newborns (EPNs) can be performed safely and with ...

One out of 10 of all babies are born premature. One in 10 babies are born premature and Irie Felkner and her twin brother, Judah Felkner, were two of them. Born 13 weeks prematurely, they were unable ...

In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...

Extremely low birth weight (ELBW) infants with moderate to large patent ductus arteriosus (PDA) may benefit from transcatheter PDA closure (TCPC) in the first four weeks of life, according to research ...

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a ...